Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
Status:
Completed
Trial end date:
2017-03-12
Target enrollment:
Participant gender:
Summary
The goal of this study is to identify a vitamin D supplementation strategy that best promotes
the lung, immune, and overall health of black infants born preterm (28-36 weeks gestational
age). This is a high risk population that seems to have unique vitamin D needs, and
inappropriate supplementation may promote wheezing or allergy. The results of this study will
help form nutritional recommendations for the approximately 100,000 black infants born at
30-36 weeks gestational age in the U.S. every year.
Phase:
Phase 4
Details
Lead Sponsor:
Case Western Reserve University
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) Office of Dietary Supplements (ODS)
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins